ICICI Prudential Nifty Pharma Index IDCW Payout Direct Plan
SIP amount
Temporarily restricted by fund house
Lumpsum amount
Temporarily restricted by fund house

ICICI Prudential Nifty Pharma Index IDCW Payout Direct Plan

NAV
₹17.6941
-0.48%
(1 Dec)
AUM
91 Cr
TER
0.37%
Risk
Very High Risk
Insights
Net Asset Value (NAV) is above its 200 days moving average
In beta. Send feedback here.
Compare with other fund
1Y
+11.3%
+11.3%
+6.2%
-2.2%
-2.2%
3Y
+25.4%
+25.4%
NA
+24.8%
+24.8%
5Y
NA
NA
NA
NA
NA
ALL
+22.6%
+22.6%
+21.8%
+17.4%
+17.4%
VOL
17.0%
17.0%
14.5%
20.3%
20.3%
TER
0.3%
0.3%
0.4%
0.5%
0.5%
AUM
₹518 Cr
₹518 Cr
₹91 Cr
₹260 Cr
₹260 Cr
INFO
1.33
1.33
1.50
0.86
0.86
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
ICICI Pru Nifty Pharma Index IDCW Payout (DP)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 31st Oct
Top holdings
Sun Pharmaceuticals Industries Ltd
22.2%
Divi's Laboratories Ltd
10.7%
Cipla Ltd
10.5%
Dr Reddy's Laboratories Ltd
9.1%
Lupin Ltd
5.9%
Torrent Pharmaceuticals Ltd
4.6%
Laurus Labs Ltd
4.6%
Aurobindo Pharma Ltd
4.0%
Alkem Laboratories Ltd
3.9%
Glenmark Pharmaceuticals Ltd
3.5%
Top industry exposure
Healthcare
100.0%
Other information
Minimum SIP
Restricted (AMC)
Minimum lumpsum
Restricted (AMC)
Additional lumpsum
Restricted (AMC)
Portfolio turnover
45%
Lock-in period
-
Exit load
No exit load
Fund objective
The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
Fund manager(s)
Nishit Patel
Ashwini Shinde

FAQs